Thus, compared with TT homozygotes, individuals with CC or CT variants of ApoA-II −265T/C polymorphism have a lower level of postprandial hypertriglyceridemia, associated with a decreased risk of cardiovascular disease [31,32]. This evidence concerns the gene APOA2 and cardiovascular disorder.